{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T22:48:06Z","timestamp":1788648486017,"version":"build-2803163510"},"reference-count":34,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2038,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1111\/j.1600-0714.2009.00873.x","type":"journal-article","created":{"date-parts":[[2010,1,26]],"date-time":"2010-01-26T03:27:10Z","timestamp":1264476430000},"page":"155-161","source":"Crossref","is-referenced-by-count":27,"title":["Polymorphisms in the apoptosis-associated genes FAS and FASL and risk of oral cancer and malignant potential of oral premalignant lesions in a Taiwanese population"],"prefix":"10.1111","volume":"39","author":[{"given":"Li-Hsuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo-Chun","family":"Ting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Ho","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Cheng","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Lung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ta-Chih","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Wen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Ling","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Chu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"10.1111\/j.1600-0714.2009.00873.x-BIB1","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1002\/ijc.22657","article-title":"Expression of NF-kappaB parallels COX-2 expression in oral precancer and cancer: association with smokeless tobacco","volume":"120","author":"Sawhney","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1111\/j.1600-0714.2009.00873.x-BIB2","volume-title":"Health and vital statistics, Republic of China 2007","author":"Department of Health","year":"2008"},{"key":"10.1111\/j.1600-0714.2009.00873.x-BIB3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1601-0825.2006.01349.x","article-title":"Molecular genetics of premalignant oral lesions","volume":"13","author":"Mithani","year":"2007","journal-title":"Oral Dis"},{"key":"10.1111\/j.1600-0714.2009.00873.x-BIB4","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/35077213","article-title":"Proliferation, cell cycle and apoptosis in cancer","volume":"411","author":"Evan","year":"2001","journal-title":"Nature"},{"key":"10.1111\/j.1600-0714.2009.00873.x-BIB5","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1093\/carcin\/bgm211","article-title":"Genetic polymorphisms in the apoptosis-associated genes FAS and FASL and breast cancer risk","volume":"28","author":"Crew","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1111\/j.1600-0714.2009.00873.x-BIB6","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S1368-8375(99)00029-9","article-title":"Up-regulation of Fas ligand and down-regulation of Fas expression in oral carcinogenesis","volume":"35","author":"Chen","year":"1999","journal-title":"Oral Oncol"},{"key":"10.1111\/j.1600-0714.2009.00873.x-BIB7","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1002\/cncr.23472","article-title":"Genetic variants in cell cycle control pathway confer susceptibility to bladder cancer","volume":"112","author":"Ye","year":"2008","journal-title":"Cancer"},{"key":"10.1111\/j.1600-0714.2009.00873.x-BIB8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/ng0308-257","article-title":"Risk loci, biological candidates and biomarkers","volume":"40","author":"Anonymous","year":"2008","journal-title":"Nat Genet"},{"key":"10.1111\/j.1600-0714.2009.00873.x-BIB9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0161-5890(97)00081-3","article-title":"Identification and characterization of polymorphisms in the promoter region of the human Apo-1\/Fas (CD95) gene","volume":"34","author":"Huang","year":"1997","journal-title":"Mol Immunol"},{"key":"10.1111\/j.1600-0714.2009.00873.x-BIB10","first-page":"4327","article-title":"Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia","volume":"63","author":"Sibley","year":"2003","journal-title":"Cancer Res"},{"key":"10.1111\/j.1600-0714.2009.00873.x-BIB11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4049\/jimmunol.170.1.132","article-title":"A novel polymorphic CAAT\/enhancer-binding protein beta element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients","volume":"170","author":"Wu","year":"2003","journal-title":"J Immunol"},{"key":"10.1111\/j.1600-0714.2009.00873.x-BIB12","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.oraloncology.2007.10.006","article-title":"Polymorphisms of COX-2-765G>C and p53 codon 72 and risks of oral squamous cell carcinoma in a Taiwan population","volume":"44","author":"Lin","year":"2008","journal-title":"Oral Oncol"},{"key":"10.1111\/j.1600-0714.2009.00873.x-BIB13","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/jnci\/djh187","article-title":"Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma","volume":"96","author":"Sun","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1600-0714.2009.00873.x-BIB14","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1093\/bioinformatics\/bti282","article-title":"PowerMarker: an integrated analysis environment for genetic marker analysis","volume":"21","author":"Liu","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1111\/j.1600-0714.2009.00873.x-BIB15","first-page":"663","article-title":"Fas-1377 A\/G polymorphism in lung cancer","volume":"21","author":"Gormus","year":"2007","journal-title":"In Vivo"},{"key":"10.1111\/j.1600-0714.2009.00873.x-BIB16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.lungcan.2006.09.002","article-title":"Polymorphisms in the FAS and FASL genes and risk of lung cancer in a Korean population","volume":"54","author":"Park","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1111\/j.1600-0714.2009.00873.x-BIB17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/jmg.2004.030106","article-title":"Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer","volume":"42","author":"Zhang","year":"2005","journal-title":"J Med Genet"},{"key":"10.1111\/j.1600-0714.2009.00873.x-BIB18","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/carcin\/bgl250","article-title":"Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer","volume":"28","author":"Zhang","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1111\/j.1600-0714.2009.00873.x-BIB19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergencyto.2007.09.002","article-title":"FAS -1377\u2003G\/A polymorphism and the risk of lymph node metastasis in cervical cancer","volume":"180","author":"Kang","year":"2008","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1111\/j.1600-0714.2009.00873.x-BIB20","first-page":"809","article-title":"Fas\/APO-1 promoter polymorphism is not associated with non-melanoma skin cancer","volume":"10","author":"Nelson","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1111\/j.1600-0714.2009.00873.x-BIB21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-5002(03)00276-9","article-title":"Fas A670G polymorphism, apoptotic capacity in lymphocyte cultures, and risk of lung cancer","volume":"42","author":"Wang","year":"2003","journal-title":"Lung Cancer"},{"issue":"Suppl. 3","key":"10.1111\/j.1600-0714.2009.00873.x-BIB22","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1525-1438.2005.00433.x","article-title":"Interleukin-10 and Fas polymorphisms and susceptibility for (pre) neoplastic cervical disease","volume":"15","author":"Zoodsma","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"10.1111\/j.1600-0714.2009.00873.x-BIB23","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/sj.cdd.4402022","article-title":"Hypoxia induces p53-dependent transactivation and Fas\/CD95-dependent apoptosis","volume":"14","author":"Liu","year":"2007","journal-title":"Cell Death Differ"},{"key":"10.1111\/j.1600-0714.2009.00873.x-BIB24","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1600-0714.2007.00625.x","article-title":"Upregulation of HIF-1alpha in malignant transformation of oral submucous fibrosis","volume":"37","author":"Tilakaratne","year":"2008","journal-title":"J Oral Pathol Med"},{"key":"10.1111\/j.1600-0714.2009.00873.x-BIB25","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.4161\/cc.7.9.5804","article-title":"Hypoxia-inducible factor signaling in the development of tissue fibrosis","volume":"7","author":"Higgins","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1111\/j.1600-0714.2009.00873.x-BIB26","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1600-0463.2007.apm_610.x","article-title":"Hypoxia-inducible factor-1alpha expression in experimental cirrhosis: correlation with vascular endothelial growth factor expression and angiogenesis","volume":"115","author":"Bozova","year":"2007","journal-title":"APMIS"},{"key":"10.1111\/j.1600-0714.2009.00873.x-BIB27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.canlet.2008.02.028","article-title":"Reactive oxygen species and HIF-1 signalling in cancer","volume":"266","author":"Galanis","year":"2008","journal-title":"Cancer Lett"},{"key":"10.1111\/j.1600-0714.2009.00873.x-BIB28","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1158\/1535-7163.MCT-04-0344","article-title":"Histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis through both mitochondrial and Fas (Cd95) signaling in head and neck squamous carcinoma cells","volume":"6","author":"Gillenwater","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1111\/j.1600-0714.2009.00873.x-BIB29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1600-0714.1997.tb00022.x","article-title":"Immunohistochemical detection of Fas antigen in oral epithelia","volume":"26","author":"Muraki","year":"1997","journal-title":"J Oral Pathol Med"},{"key":"10.1111\/j.1600-0714.2009.00873.x-BIB30","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1368-8375(98)80007-9","article-title":"Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands","volume":"34","author":"Schepman","year":"1998","journal-title":"Oral Oncol"},{"key":"10.1111\/j.1600-0714.2009.00873.x-BIB31","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/1097-0142(19840201)53:3<563::AID-CNCR2820530332>3.0.CO;2-F","article-title":"Oral leukoplakia and malignant transformation. A follow-up study of 257 patients","volume":"53","author":"Silverman","year":"1984","journal-title":"Cancer"},{"key":"10.1111\/j.1600-0714.2009.00873.x-BIB32","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1399-0039.2004.00287.x","article-title":"Cytokine gene polymorphisms in Taiwan","volume":"64","author":"Trejaut","year":"2004","journal-title":"Tissue Antigens"},{"key":"10.1111\/j.1600-0714.2009.00873.x-BIB33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000081452","article-title":"The size of the chi-square test for the Hardy-Weinberg law","volume":"58","author":"Kang","year":"2004","journal-title":"Hum Hered"},{"key":"10.1111\/j.1600-0714.2009.00873.x-BIB34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ygyno.2005.05.010","article-title":"Genetic polymorphisms of FAS and FASL (CD95\/CD95L) genes in cervical carcinogenesis: an analysis of haplotype and gene-gene interaction","volume":"99","author":"Lai","year":"2005","journal-title":"Gynecol Oncol"}],"container-title":["Journal of Oral Pathology &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0714.2009.00873.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0714.2009.00873.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T11:05:18Z","timestamp":1625655918000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0714.2009.00873.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0714.2009.00873.x","relation":{},"ISSN":["0904-2512","1600-0714"],"issn-type":[{"value":"0904-2512","type":"print"},{"value":"1600-0714","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}